ROLE OF PRENATAL ULTRASONOGRAPHY IN WOMEN WITH POSITIVE SCREEN FOR DOWN-SYNDROME ON THE BASIS OF MATERNAL SERUM MARKERS

被引:71
|
作者
NYBERG, DA
LUTHY, DA
CHENG, EY
SHELEY, RC
RESTA, RG
WILLIAMS, MA
机构
[1] UNIV WASHINGTON,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195
[2] SWEDISH MED CTR,MED CTR,CTR PERINATAL STUDIES,SEATTLE,WA
关键词
FETUS; CHROMOSOME ABNORMALITIES; PRENATAL ULTRASONOGRAPHY; PRENATAL DIAGNOSIS; DOWN SYNDROME; ALPHA-FETOPROTEIN; TRIPLE SCREEN;
D O I
10.1016/0002-9378(95)91322-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers - maternal serum ol-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. STUDY DESIGN: A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk greater than or equal to 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pylectasis, and shortened femur. RESULTS: Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered. CONCLUSION: Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.
引用
收藏
页码:1030 / 1035
页数:6
相关论文
共 50 条
  • [21] MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN AND PREGNANCY-ASSOCIATED PLASMA PROTEIN-A, MARKERS FOR FETAL DOWN-SYNDROME AT 8-14 WEEKS
    MACINTOSH, MCM
    ILES, R
    TEISNER, B
    SHARMA, K
    CHARD, T
    GRUDZINSKAS, JG
    WARD, RHT
    MULLER, F
    PRENATAL DIAGNOSIS, 1994, 14 (03) : 203 - 208
  • [22] Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome
    Lerthiranwong, Thitikarn
    Wanapirak, Chanane
    Sirichotiyakul, Supatra
    Tongprasert, Fuanglada
    Srisupundit, Kasemsri
    Luewan, Suchaya
    Tongsong, Theera
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (21) : 2847 - 2851
  • [23] MATERNAL SERUM-FREE BETA-HCG SCREENING - RESULTS OF STUDIES INCLUDING 480 CASES OF DOWN-SYNDROME
    MACRI, JN
    SPENCER, K
    GARVER, K
    BUCHANAN, PD
    SAY, B
    CARPENTER, NJ
    MULLER, F
    BOUE, A
    PRENATAL DIAGNOSIS, 1994, 14 (02) : 97 - 103
  • [24] NEW ESTIMATES OF DOWN-SYNDROME RISKS AT CHORIONIC VILLUS SAMPLING, AMNIOCENTESIS, AND LIVEBIRTH IN WOMEN OF ADVANCED MATERNAL AGE FROM A UNIQUELY DEFINED POPULATION
    HALLIDAY, JL
    WATSON, LF
    LUMLEY, J
    DANKS, DM
    SHEFFIELD, LJ
    PRENATAL DIAGNOSIS, 1995, 15 (05) : 455 - 465
  • [25] How to correct the impact of ethnicity on effectiveness of the second trimester maternal serum screen of fetal Down syndrome?
    Tana, Chonthicha
    Wanapirak, Chanane
    Sirichotiyakul, Supatra
    Tongprasert, Fuanglada
    Srisupundit, Kasemsri
    Luewan, Suchaya
    Sekararithi, Ratanaporn
    Tongsong, Theera
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (20) : 3343 - 3347
  • [26] Analysis of External Quality Assessment of Maternal Serum Prenatal Screening for Down Syndrome in the First Trimester in China
    He, Falin
    Wang, Wei
    Zhong, Kun
    Yuan, Shuai
    Du, Yuxuan
    Wang, Zhiguo
    CLINICAL LABORATORY, 2021, 67 (06) : 1357 - 1364
  • [27] Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies
    Huang, Tianhua
    Boucher, Karen
    Summers, Anne M.
    PRENATAL DIAGNOSIS, 2007, 27 (12) : 1138 - 1142
  • [28] Detection and false-positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages
    Muller, F
    Thalabard, JC
    Ngo, S
    Dommergues, M
    PRENATAL DIAGNOSIS, 2002, 22 (05) : 350 - 353
  • [29] Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis
    Kang, Yuan
    Dong, Xinran
    Zhou, Qiongjie
    Zhang, Ying
    Cheng, Yan
    Hu, Rong
    Su, Cuihong
    Jin, Hong
    Liu, Xiaohui
    Ma, Duan
    Tian, Weidong
    Li, Xiaotian
    PRENATAL DIAGNOSIS, 2012, 32 (03) : 284 - 292
  • [30] Foetal Down syndrome risk evaluation by maternal serum markers: Influence of analytical errors on computed risk
    Morin, J. -F.
    Morin, V.
    Moineau, M. -P.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (03): : 126 - 134